JW Shinyak Corporation (067290) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.115x

Based on the latest financial reports, JW Shinyak Corporation (067290) has a cash flow conversion efficiency ratio of 0.115x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.46 Billion ≈ $3.03 Million USD) by net assets (₩38.73 Billion ≈ $26.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of JW Shinyak Corporation to measure how much of total assets are equity-financed.

JW Shinyak Corporation - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how JW Shinyak Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 067290 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

JW Shinyak Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JW Shinyak Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Plastiblends India Limited NSE:PLASTIBLEN	-0.001x
Inzi Controls KO:023800	0.142x
Baolong International Co Ltd TW:1906	0.027x
Evrofarma SA AT:EVROF	-0.018x
Blue Lagoon Resources Inc F:7BL	-0.071x
Taiwan Wax Co Ltd TWO:1742	-0.014x
Roundtop Machinery Industries Co Ltd TW:1540	0.023x
Imas Makina Sanayi AS IS:IMASM	0.046x

Annual Cash Flow Conversion Efficiency for JW Shinyak Corporation (2007–2024)

The table below shows the annual cash flow conversion efficiency of JW Shinyak Corporation from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 067290 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩26.90 Billion ≈ $18.23 Million	₩8.44 Billion ≈ $5.72 Million	0.314x	+101.71%
2023-12-31	₩16.44 Billion ≈ $11.14 Million	₩2.56 Billion ≈ $1.73 Million	0.156x	+22.16%
2022-12-31	₩55.97 Billion ≈ $37.93 Million	₩7.13 Billion ≈ $4.83 Million	0.127x	-9.16%
2021-12-31	₩55.44 Billion ≈ $37.57 Million	₩7.77 Billion ≈ $5.27 Million	0.140x	+93.40%
2020-12-31	₩56.56 Billion ≈ $38.33 Million	₩4.10 Billion ≈ $2.78 Million	0.072x	+11.25%
2019-12-31	₩66.14 Billion ≈ $44.82 Million	₩4.31 Billion ≈ $2.92 Million	0.065x	-70.53%
2018-12-31	₩33.49 Billion ≈ $22.69 Million	₩7.40 Billion ≈ $5.02 Million	0.221x	+426.23%
2017-12-31	₩36.83 Billion ≈ $24.96 Million	₩-2.50 Billion ≈ $-1.69 Million	-0.068x	-451.98%
2016-12-31	₩38.60 Billion ≈ $26.16 Million	₩743.20 Million ≈ $503.66K	0.019x	+3608.61%
2015-12-31	₩40.23 Billion ≈ $27.26 Million	₩-22.08 Million ≈ $-14.96K	-0.001x	+98.99%
2014-12-31	₩42.46 Billion ≈ $28.77 Million	₩-2.31 Billion ≈ $-1.56 Million	-0.054x	-246.92%
2011-12-31	₩52.81 Billion ≈ $35.79 Million	₩1.95 Billion ≈ $1.32 Million	0.037x	-65.66%
2007-12-31	₩27.49 Billion ≈ $18.63 Million	₩2.96 Billion ≈ $2.01 Million	0.108x	--

About JW Shinyak Corporation

KQ:067290 Korea Pharmaceuticals

Market Cap

$52.31 Million

₩77.20 Billion KRW

Market Cap Rank

#21645 Global

#1262 in Korea

Share Price

₩1858.00

Change (1 day)

+2.60%

52-Week Range

₩1254.00 - ₩3105.00

All Time High

₩10766.98